A phase II trial of low-dose multiagent chemotherapy with gemcitabine, docetaxel, capecitabine, and cisplatin (GTX-C) in patients with metastatic pancreatic cancer.
暂无分享，去创建一个
L. Diaz | R. Donehower | D. Cosgrove | D. Laheru | R. Parkinson | N. Azad | Z. Rasheed | D. Le | J. Uram | I. Browner | A. Jesus-Acosta | Hao Wang | D. Savage | L. Zheng | S. Lawrence | Katrina Purtell | Ellen-Lilly Foreman | Jacob Joseph David